NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer

Tatsuhiro Shibata, Akiko Kokubu, Shigeru Saito, Mako Narisawa-Saito, Hiroki Sasaki, Kazuhiko Aoyagi, Yuki Yoshimatsu, Yuji Tachimori, Ryoji Kushima, Tohru Kiyono, Masayuki Yamamoto

Research output: Contribution to journalArticlepeer-review

140 Citations (Scopus)

Fingerprint Dive into the research topics of 'NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences